GTBP Earnings GT Biopharma, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–42 of 42
| Q2 2026 | 2026-06-30 | -0.23 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.11 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -6.68 | 2026-03-02 | 10-K |
| FY 2025 | 2025-09-30 | -8.90 | 2026-03-02 | 10-K |
| Q2 2026 | 2025-06-30 | -12.12 | 2026-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.33 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -6.94 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -5.28 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.86 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.64 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -5.64 | 2025-02-21 | 10-K |
| Q3 2024 | 2023-09-30 | -3.47 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.68 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.21 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -19.66 | 2024-03-26 | 10-K |
| Q3 2023 | 2022-09-30 | -0.48 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.26 | 2023-08-07 | 10-Q |
| Q1 2020 | 2020-03-31 | -0.02 | 2020-05-15 | 10-Q |
| Q1 2020 | 2019-03-31 | -0.09 | 2020-05-15 | 10-Q |
| FY 2018 | 2018-12-31 | -5.16 | 2019-03-29 | 10-K |
| Q3 2018 | 2018-09-30 | -5.09 | 2018-11-14 | 10-Q |
| Q2 2018 | 2018-06-30 | 50117977.00 | 2018-08-14 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.20 | 2019-05-15 | 10-Q |
| FY 2018 | 2017-12-31 | -8.60 | 2019-03-29 | 10-K |
| Q3 2018 | 2017-09-30 | -24.54 | 2018-11-14 | 10-Q |
| Q2 2018 | 2017-06-30 | 335450.00 | 2018-08-14 | 10-Q |
| Q1 2018 | 2017-03-31 | -26.36 | 2018-05-15 | 10-Q |
| FY 2017 | 2016-12-31 | 119.91 | 2018-03-01 | 10-K |
| Q3 2017 | 2016-09-30 | 315.96 | 2017-11-14 | 10-Q |
| Q2 2017 | 2016-06-30 | 404.78 | 2017-08-11 | 10-Q |
| Q1 2017 | 2016-03-31 | 1.49 | 2017-04-28 | 10-Q |
| Q3 2016 | 2015-09-30 | 0.98 | 2016-11-14 | 10-Q |
| Q2 2016 | 2015-06-30 | 4899898.00 | 2016-08-10 | 10-Q |
| Q1 2016 | 2015-03-31 | -8.61 | 2016-05-13 | 10-Q |
| Q3 2015 | 2014-09-30 | -0.01 | 2015-11-13 | 10-Q |
| Q2 2015 | 2014-06-30 | 0.00 | 2015-08-14 | 10-Q |
| Q1 2015 | 2014-03-31 | 0.00 | 2015-05-14 | 10-Q |
| Q3 2014 | 2013-09-30 | 0.00 | 2015-01-08 | 10-Q |
| Q2 2014 | 2013-06-30 | 0.00 | 2015-01-08 | 10-Q |
| Q1 2014 | 2013-03-31 | 0.00 | 2015-01-08 | 10-Q |
| Q2 2013 | 2012-06-30 | -0.01 | 2014-12-12 | 10-Q |
| Q1 2013 | 2012-03-31 | 0.00 | 2014-12-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.